Association of polymorphisms of ABCA1 and ROS1 with hypertension in Japanese individuals

International Journal of Molecular Medicine

Volumn 21, Issue 1, 2008, Pages 83-89

  Yamada, Yoshiji ^a   Kato, Kimihiko ^b   Yoshida, Tetsuro ^b   Yokoi, Kiyoshi ^b   Matsuo, Hitoshi ^c   Watanabe, Sachiro ^c   Ichihara, Sahoko ^a   Metoki, Norifumi ^d   Yoshida, Hidemi ^e   Satoh, Kei ^e   Aoyagi, Yukitoshi ^f   Yasunaga, Akitomo ^f   Park, Hyuntae ^f   Tanaka, Masashi ^f   Nozawa, Yoshinori ^g  

^a MIE UNIVERSITY   (Japan)

^b GIFU PREFECTURAL TAJIMI HOSPITAL   (Japan)

^c GIFU PREFECTURAL GIFU HOSPITAL   (Japan)

^d Hirosaki Stroke Center   (Japan)

^e HIROSAKI UNIVERSITY   (Japan)

^f TOKYO METROPOLITAN INSTITUTE OF GERONTOLOGY   (Japan)

^g GIFU INTERNATIONAL INSTITUTE OF BIOTECHNOLOGY   (Japan)

Author keywords

ABCA1; Genetics; Hypertension; Polymorphism; ROS1

Indexed keywords

ABC TRANSPORTER A1; ADENINE; ADIPONECTIN RECEPTOR 1; ASPARAGINE; CYSTEINE; CYTOCHROME P450 3A4; CYTOSINE; GUANINE; INTERSTITIAL COLLAGENASE; ISOLEUCINE; LOW DENSITY LIPOPROTEIN RECEPTOR; ONCOPROTEIN; PROTEIN ROS1; SERINE; THYMINE; UNCLASSIFIED DRUG; VALINE;

ADULT; AGE; AGED; ARTICLE; BODY MASS; CHI SQUARE TEST; CONTROLLED STUDY; DIABETES MELLITUS; DIASTOLIC BLOOD PRESSURE; DISEASE PREDISPOSITION; DISEASE RESISTANCE; DNA MICROARRAY; FEMALE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; JAPANESE; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; NUCLEOTIDE SEQUENCE; OLIGONUCLEOTIDE PROBE; PATHOGENESIS; POLYMERASE CHAIN REACTION; PREDICTION; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; SEX; SMOKING; STATISTICAL SIGNIFICANCE; SYSTOLIC BLOOD PRESSURE;

EID: 38949149650     PISSN: 11073756     EISSN: None     Source Type: Journal    
DOI: 10.3892/ijmm.21.1.83     Document Type: Article

References (35)

1. Lifton RP, Gharavi AG and Geller DS: Molecular mechanisms of human hypertension. Cell 104: 545-556, 2001.
2. Turner ST, Schwartz GL and Boerwinkle E: Personalized medicine for high blood pressure. Hypertension 50: 1-5, 2007.
3. Caulfield M, Munroe P, Pembroke J, et al: Genome-wide mapping of human loci for essential hypertension. Lancet 361: 2118-2123, 2003.
4. Gong M, Zhang H, Schulz H, et al: Genome-wide linkage reveals a locus for human essential (primary) hypertension on chromosome 12p. Hum Mol Genet 12: 1273-1277, 2003.
5. de Lange M, Spector TD and Andrew T: Genome-wide scan for blood pressure suggests linkage to chromosome 11, and replication of loci on 16, 17, and 22. Hypertension 44: 872-877, 2004.
6. Wallace C, Xue MZ, Newhouse SJ, et al: Linkage analysis using co-phenotypes in the BRIGHT study reveals novel potential susceptibility loci for hypertension. Am J Hum Genet 79: 323-331, 2006.
7. Cusi D, Barlassina C, Azzani T, et al: Polymorphisms of α-adducin and salt sensitivity in patients with essential hypertension. Lancet 349: 1353-1357, 1997.
8. Siffert W, Rosskopf D, Siffert G, et al: Association of a human G-protein 83 subunit variant with hypertension. Nat Genet 18: 45-48, 1998.
9. Izawa H, Yamada Y, Okada T, Tanaka M, Hirayama H and Yokota M: Prediction of genetic risk for hypertension. Hypertension 41: 1035-1040, 2003.
10. Yamada Y, Matsuo H, Segawa T, et al: Assessment of the genetic component of hypertension. Am J Hypertens 19: 1158-1165, 2006.
11. Yamada Y, Ando F and Shimokata H: Association of a microsomal triglyceride transfer protein gene polymorphism with blood pressure in Japanese women. Int J Mol Med 17: 83-88, 2006.
12. Yamada Y, Ando F and Shimokata H: Association of gene polymorphisms with blood pressure and the prevalence of hypertension in community-dwelling Japanese individuals. Int J Mol Med 19: 675-683, 2007.
13. Perloff D, Grim C, Flack J, et al: Human blood pressure determination by sphygmomanometry. Circulation 88: 2460-2470, 1993.
14. Itoh Y, Mizuki N, Shimada T, et al: High-throughput DNA typing of HLA-A, -B, -C, and -DRB1 loci by a PCR-SSOP-Luminex method in the Japanese population. Immunogenetics 57: 717-729, 2005.
15. Oram JF and Heinecke JW: ATP-binding cassette transporter A1: a cell cholesterol exporter that protects against cardiovascular disease. Physiol Rev 85: 1343-1372, 2005.
16. Lusis AJ: Atherosclerosis. Nature 407: 233-241, 2000.
17. Brooks-Wilson A, Marcil M, Clee SM, et al: Mutations in ABC1 in Tangier disease and familial high-density lipoprotein deficiency. Nat Genet 22: 336-345, 1999.
18. Bodzioch M, Orso E, Klucken J, et al: The gene encoding ATP-binding cassette transporter 1 is mutated in Tangier disease. Nat Genet 22: 347-351, 1999.
19. Rust S, Rosier M, Funke H, et al: Tangier disease is caused by mutations in the gene encoding ATP-binding cassette transporter 1. Nat Genet 22: 352-355, 1999.
20. Clee SM, Kastelein JJ, van Dam M, et al: Age and residual cholesterol efflux affect HDL cholesterol levels and coronary artery disease in ABCA1 heterozygotes. J Clin Invest 106: 1263-1270, 2000.
21. van Dam MJ, de Groot GE, Clee SM, et al: Association between increased arterial-wall thickness and impairment in ABCAI-driven cholesterol efflux: an observational study. Lancet 359: 37-42, 2002,
22. Wang J, Burnett JR, Near S, et al: Common and rare ABCA1 variants affecting plasma HDL cholesterol. Arterioscler Thromb Vase Biol 20: 1983-1989, 2000.
23. Clee SM, Zwinderman AH, Engert JC, et at: Common genetic variation in ABCA1 is associated with altered lipoprotein levels and a modified risk for coronary artery disease. Circulation 103: 1199-1205, 2001.
24. Kyriakou T, Pontefract DE, Viturro E, et al: Functional polymorphism in ABCA1 influences age of symptom onset in coronary artery disease patients. Hum Mol Genet 16: 1412-1422, 2007.
25. Tregouet DA, Ricard S, Nicaud V, et al: In-depth haplotype analysis of ABCA1 gene polymorphisms in relation to plasma ApoA1 levels and myocardial infarction. Arterioscler Thromb Vase Biol 24: 775-781, 2004.
26. Frikke-Schmidt R, Nordestgaard BG, Jensen GB and Tybjaerg-Hansen A: Genetic variation in ABC transporter A1 contributes to HDL cholesterol in the general population. J Clin Invest 114: 1343-1353,2004.
27. Kyriakou T, Hodgkinson C, Pontefract DE, et al: Genotypic effect of the -565C→T polymorphism in the ABCA1 gene promoter on ABCA1 expression and severity of atherosclerosis. Arterioscler Thromb Vase Biol 25: 418-423, 2005.
28. Tan JH, Low PS, Tan YS, et al: ABCA1 gene polymorphisms and their associations with coronary artery disease and plasma lipids in males from three ethnic populations in Singapore. Hum Genet 113: 106-117, 2003.
29. Hodoglugil U, Williamson DW, Huang Y and Mahley RW: Common polymorphisms of ATP binding cassette transporter Al, including a functional promoter polymorphism, associated with plasma high density lipoprotein cholesterol levels in Turks. Atherosclerosis 183: 199-212, 2005.
30. Schlessinger J: Cell signaling by receptor tyrosine kinases. Cell 103: 211-225, 2000.
31. Zong CS, Chan JL, Yang SK, et al: Mutations of Ros differentially effecting signal transduction pathways leading to cell growth versus transformation. J Biol Chem 272: 1500-1506, 1997.
32. Neckameyer WS and Wang LH: Nucleotide sequence of avian sarcoma virus UR2 and comparison of its transforming gene with other members of the tyrosine protein kinase oncogene family. J Virol 53: 879-884, 1985.
33. Birchmeier C, O'Neill K, Riggs M, et al: Characterization of ROS1 cDNA from a human glioblastoma cell line. Proc Natl Acad Sci USA 87: 4799-4803, 1990.
34. Shiffman D, Ellis SG, Rowland CM, et al: Identification of four gene variants associated with myocardial infarction. Am J Hum Genet 77: 596-605, 2005.
35. Zee RY, Michaud SE, Hegener HH, Diehl KA and Ridker PM: A prospective replication study of five gene variants previously associated with risk of myocardial infarction. J Thromb Haemost 4: 2093-2095, 2006.